RxDoctor Payments Data

Meaghan Reynolds, PA

Physician Assistant · North Easton, MANPI 1477782324

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.7% of the total across 1,107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 58 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,757in general payments, 2019–2025

Across 1,107 payments — averaging $21.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Lundbeck LLC$2K
  • Novartis$2K
  • Biogen$1K
  • SK Life Science, Inc.$1K
  • MDD US Operations, LLC$948
  • plus $14K from 52 others

What the payments were for

  • Speaking & faculty fees$650%
  • Food & beverage$23,43899%
  • Education$2541%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)161$3,072
Lundbeck LLC79$1,781
Novartis69$1,690
Biogen61$1,234
SK Life Science, Inc.43$1,148
MDD US Operations, LLC36$948
Teva Pharmaceuticals USA, Inc.58$886
CSL Behring35$843
Pfizer48$737
ANI Pharmaceuticals, Inc.24$726
Eisai Inc.29$717
UCB, Inc.40$680
Amneal Pharmaceuticals LLC30$676
Lilly USA, LLC38$672
AstraZeneca(2 entities)28$670
EMD Serono, Inc.23$664
Mallinckrodt Hospital Products Inc.18$659
Merz Pharmaceuticals, LLC23$657
Bristol Myers Squibb24$459
Sanofi18$427
Amgen13$330
Johnson & Johnson13$292
Genentech USA, Inc.17$291
Alnylam Pharmaceuticals Inc.8$273
Sunovion Pharmaceuticals Inc.14$263
Biohaven Pharmaceuticals, Inc.13$262
Biohaven Pharmaceutical Holding Company Ltd.18$261
Neurocrine Biosciences, Inc.11$230
Otsuka America Pharmaceutical, Inc.10$229
Axsome Therapeutics, Inc.12$204
Neurelis, Inc.10$192
TG Therapeutics, Inc.7$151
Grifols USA, LLC8$141
Tanabe Pharma America, Inc.6$135
Acadia Pharmaceuticals Inc7$130
Impel Pharmaceuticals Inc.5$112
Supernus Pharmaceuticals, Inc.10$101
Argenx US, Inc.5$100
Takeda Pharmaceuticals U.S.A., Inc.5$93
Kyowa Kirin, Inc.4$79
Idorsia Pharmaceuticals US Inc4$77
Harmony Biosciences LLC1$73
Acorda Therapeutics, Inc3$65
GE HealthCare2$43
Life Molecular Imaging Ltd2$34
Scilex Pharmaceuticals Inc.1$25
Vanda Pharmaceuticals Inc.1$25
Amylyx Pharmaceuticals, Inc.1$24
Insightec,inc1$23
Corium, LLC2$22
Kedrion Biopharma, Inc.1$21
Jazz Pharmaceuticals Inc.1$20
Cycle Pharmaceuticals Inc1$20
Catalyst Pharmaceuticals, Inc.1$19
Vertex1$15
Xeris Pharmaceuticals, Inc.1$14
Avion Pharmaceuticals1$14
Upsher-smith Laboratories LLC1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,757 in reported general payments places this provider in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

See all physician assistant providers in Massachusetts

Medicare billing

Part B allowed, 2024
$37,764
Medicare patients
137
Services billed
749

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate55$91,633
BotoxOnabotulinumtoxina17$21,337
UbrelvyUbrogepant12$19,852
Ajovy AutoinjectorFremanezumab-Vfrm11$19,126
VraylarCariprazine Hcl11$18,144
Lacosamide45$7,452
Rivastigmine25$4,522
Memantine Hcl95$3,588
Gabapentin138$1,884
Duloxetine Hcl36$1,446
Donepezil Hcl116$1,328
Pregabalin107$1,317
Levetiracetam40$1,273
Carbidopa-LevodopaCarbidopa/Levodopa51$1,209
Lamotrigine40$1,180

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$737$91,63355 claims
AbbVieBotox, Ubrelvy, Vraylar$3,072$59,33440 claims
Upsher-smith Laboratories LLCTopiramate$12$73054 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,507 physician assistant providers in Massachusetts.

Other physician assistant in North Easton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →